Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762281 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia
A NA study, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- NA
- Development phase
- 189
- Enrollment target
NCT00762281 is a NA study that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 189 participants.
The verdict
NCT00762281, a NA study, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- NA
- Development phase
- 189 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of hyperopia, when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.
Interventions
- DEVICE MEL 80 Hyperopic LASIK Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00762281
The ClinicalTrials.gov registry entry for NCT00762281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEL 80 Hyperopic LASIK Treatment is the first listed.
NCT00762281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00762281 about?
NCT00762281 is a clinical study titled "Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia". The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of hyperopia, when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.
What is the current status of trial NCT00762281?
This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2004-07. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00762281?
The interventions under investigation include: MEL 80 Hyperopic LASIK Treatment (DEVICE).
Who is sponsoring clinical trial NCT00762281?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.